Health Care & Life Sciences » Biotechnology | Neptune Technologies & Bioressources Inc.

Neptune Technologies & Bioressources Inc. | Cash Flow

Fiscal year is April-March. All values CAD Thousands.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
11,042.50
29,822.30
10,829.70
879.80
9,339.40
23,191.70
Depreciation, Depletion & Amortization
352.90
1,718.70
2,579.60
3,816.80
3,541.90
3,056.30
Other Funds
8,408.30
-
0.80
-
322.50
3,917.60
Funds from Operations
7,311.80
33,891.20
12,073.70
6,979.00
15,748.40
16,217.80
Changes in Working Capital
10,808.30
10,463.60
135.00
1,318.80
7,516.00
8,004.50
Net Operating Cash Flow
18,120.10
23,427.60
12,208.80
5,660.20
8,232.40
8,213.30
Capital Expenditures
16,894.50
18,042.60
1,299.50
4,657.70
5,051.00
Sale of Fixed Assets & Businesses
-
-
-
-
43,075.60
Purchase/Sale of Investments
9,308.00
1,894.40
13,665.20
7,604.60
439.10
Net Investing Cash Flow
26,202.60
16,148.20
5,485.70
2,946.90
35,797.50
Issuance/Reduction of Debt, Net
22.30
4,411.30
7,709.30
5,028.10
18,939.40
Net Financing Cash Flow
35,028.30
37,038.00
7,736.90
1,853.00
19,011.70
Net Change in Cash
8,380.10
2,269.30
1,219.90
10,329.40
8,484.70
Free Cash Flow
34,622.80
41,354.30
13,408.50
2,717.90
9,499.70
Net Assets from Acquisitions
-
-
6,879.90
-
2,666.10
Change in Capital Stock
26,642.30
32,626.70
28.40
6,881.00
250.20
Exchange Rate Effect
914.30
268.60
205.90
130.60
68.70

About Neptune Technologies & Bioressources

View Profile
Address
545, Promenade du Centropolis
Laval Québec H7T 0A3
Canada
Employees -
Website http://www.neptunecorp.com
Updated 07/08/2019
Neptune Technologies & Bioresources, Inc. engages in the development and commercialization specialty ingredients. It offers the MaxSimil a patented ingredient that may enhance the absorption of lipid-based nutraceuticals, and a variety of other marine and seed oils. It operates through the Nutraceutical, Cannabis, and Cardiovascular segments.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.